close


發佈日期:2014年2月6日
 
糖尿病新藥-SGLT2抑制劑助排糖 腎功能不佳者不適用
 

The management of Type 2 Diabetes (T2D) is complex and challenging.

Sodium glucose cotransporter 2 (SGLT2) inhibition offers a different mode of action from other oral glucose lowering treatments.

Find out more about SGLT2 inhibition and its potential impact on T2D management.

arrow
arrow
    文章標籤
    SGLT2 SGLT2 Inhibition 恩排糖
    全站熱搜

    changturtle 發表在 痞客邦 留言(0) 人氣()